Aurelio Valdez-Cruz

Cuernavaca, MOR 62100, Mexico

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

Serum Antibodies Against the E5 Oncoprotein from Human Papillomavirus Type 16 Are Inversely Associated with the Infection and the Degree of Cervical Lesions.

Serum Antibodies Against the E5 Oncoprotein from Human Papillomavirus Type 16 Are Inversely Associated with the Infection and the Degree of Cervical Lesions.

Journal: Biomedicines

Published: October 08, 2024

Cervical cancer prevention by vaccination: review.

Cervical cancer prevention by vaccination: review.

Journal: Frontiers in oncology

Published: February 14, 2024

Performance of cervical cytology and HPV testing for primary cervical cancer screening in Latin America: an analysis within the ESTAMPA study.

Performance of cervical cytology and HPV testing for primary cervical cancer screening in Latin America: an analysis within the ESTAMPA study.

Journal: Lancet regional health. Americas

Published: March 03, 2023

Title Not Found

Title Not Found

Journal: Salud publica de Mexico

Published: February 14, 2023

Cervical cancer prevention program in Mexico disrupted due to COVID-19 pandemic: Challenges and opportunities.

Cervical cancer prevention program in Mexico disrupted due to COVID-19 pandemic: Challenges and opportunities.

Journal: Frontiers in oncology

Published: August 01, 2022

Implementing HPV testing in 9 Latin American countries: The laboratory perspective as observed in the ESTAMPA study.

Implementing HPV testing in 9 Latin American countries: The laboratory perspective as observed in the ESTAMPA study.

Journal: Frontiers in medicine

Published: July 28, 2022

Performance of standardised colposcopy to detect cervical precancer and cancer for triage of women testing positive for human papillomavirus: results from the ESTAMPA multicentric screening study.

Performance of standardised colposcopy to detect cervical precancer and cancer for triage of women testing positive for human papillomavirus: results from the ESTAMPA multicentric screening study.

Journal: The Lancet. Global health

Published: June 03, 2022

Differential Antibody Response against Conformational and Linear Epitopes of the L1 Proteins from Human Papillomavirus Types 16/18 Is Observed in Vaccinated Women or with Uterine Cervical Lesions.

Differential Antibody Response against Conformational and Linear Epitopes of the L1 Proteins from Human Papillomavirus Types 16/18 Is Observed in Vaccinated Women or with Uterine Cervical Lesions.

Journal: Vaccines

Published: March 23, 2021

Reduction of HPV16/18 prevalence in young women after eight years of three- and two-dose vaccination schemes.

Reduction of HPV16/18 prevalence in young women after eight years of three- and two-dose vaccination schemes.

Journal: Vaccine

Published: November 17, 2020

MOLECULAR MARKERS FOR THE DIAGNOSIS OF HIGH-RISK HUMAN PAPILLOMAVIRUS INFECTION AND TRIAGE OF HUMAN PAPILLOMAVIRUS-POSITIVE WOMEN.

MOLECULAR MARKERS FOR THE DIAGNOSIS OF HIGH-RISK HUMAN PAPILLOMAVIRUS INFECTION AND TRIAGE OF HUMAN PAPILLOMAVIRUS-POSITIVE WOMEN.

Journal: Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion

Published: October 16, 2020

Multicentric study of cervical cancer screening with human papillomavirus testing and assessment of triage methods in Latin America: the ESTAMPA screening study protocol.

Multicentric study of cervical cancer screening with human papillomavirus testing and assessment of triage methods in Latin America: the ESTAMPA screening study protocol.

Journal: BMJ open

Published: May 26, 2020

The effect of a booster dose of HPV tetravalent vaccine after 51 months: implications for extended vaccination schedules.

The effect of a booster dose of HPV tetravalent vaccine after 51 months: implications for extended vaccination schedules.

Journal: Salud publica de Mexico

Published: November 13, 2018

Showing 1-12 of 24

Last Updated: 09/26/2026